Back
  1. Home
  2. Request Item
institution logo
If you're member of the institution,  you just have to login to download the file in restricted access. It is not necessary to request a print.

Request copy

Phase III study of Ribociclib (LEE011) plus Fulvestrant for the treatment of postmenopausal patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer who have received no or only one line of prior endocrine treatment : MONALEESA-3
Fasching, P.A.; JERUSALEM, Guy; Pivot, X. et al.
2016 • In Journal of Clinical Oncology, 34, p. 624

Document(s) requested
Phase III study of Ribociclib (LEE011) plus Fulvestrant for the treatment ... abstract.pdf

The desired document is not currently available on open access. Nevertheless you can request an offprint through the form below. If your request is accepted you will receive by e-mail a link allowing you access to the document for 5 days, 5 download attempts maximum.


Request form

Fields marked with ✱ are compulsory.

Back to the reference
Contact ORBi